ExaCAR-NK

N/A

Report date: 2025/03/20 15:54:14

Base Information

Drug NameExaCAR-NK

Drug Alias NameExaCAR-NK cell therapyallogeneic iPSC-derived CAR NK-cell therapy (Exacis Biotherapeutics/Factor Bioscience)

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapy

Mechanisms of ActionImmunostimulantsNatural killer cells stimulants

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesExacis Biotherapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesExacis Biotherapeutics Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A